The clinical significance of detecting chronic myeloid leukemia bcr/abl fusion gene by real-time quantitative PCR
Tinglong Zhang
Abstract
Tinglong Zhang
Abstract
Objective To investigate the value of diagnosis and prognostic evaluation according to detect the expression of bcr/abl fusion gene in chronic myeloid leukemia by real-time quatitative PCR.Methods To use the real-time PCR to detect the expression of bcr/abl fusion gene of 39 cases chronic myeloid leukemia and 20 cases others hematological diseases.Results Marrow and peripheral blasts showed significant corrilation with the copy of bcr/abl fusion gene.Bcr/abl fusion gene expression level of newly diagnosis chronic myeloid leukemia increased significantly.After the treatment of hydroxycarbamide±interferon,the expression level of the gene decreased markedly.The patients of recurrence or acceleration phase can be found ahead of 2-4 months By the therapy of Glevec or explantation,the most of the fusion gene turned negative.Conclusion The detection of bcr/abl fusion gene is an important way to diagnose chronic myeloid leukemia,and can be a decisive index of treatment and prognostic evaluation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the value of diagnosis and prognostic evaluation according to detect the expression of bcr/abl fusion gene in chronic myeloid leukemia by real-time quatitative PCR.Methods To use the real-time PCR to detect the expression of bcr/abl fusion gene of 39 cases chronic myeloid leukemia and 20 cases others hematological diseases.Results Marrow and peripheral blasts showed significant corrilation with the copy of bcr/abl fusion gene.Bcr/abl fusion gene expression level of newly diagnosis chronic myeloid leukemia increased significantly.After the treatment of hydroxycarbamide±interferon,the expression level of the gene decreased markedly.The patients of recurrence or acceleration phase can be found ahead of 2-4 months By the therapy of Glevec or explantation,the most of the fusion gene turned negative.Conclusion The detection of bcr/abl fusion gene is an important way to diagnose chronic myeloid leukemia,and can be a decisive index of treatment and prognostic evaluation.
Key concepts: Myeloid leukemia, Fusion gene, ABL, breakpoint cluster region, Medicine, Leukemia, Cancer research, Real-time polymerase chain reaction